Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-2 and Rituximab in High Risk B Cell Non-Hodgkin's Lymphoma
NCT00994643Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Feb 2009
- Primary completion
- Jun 2014
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in Non-Hodgkin lymphoma (NHL), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Feb 2009; status: completed.
02
Drugs
aldesleukin
03
Conditions
Non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00994643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00994643.